Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
Salamone P, Fuda G, Casale F, Marrali G, Lunetta C, Caponnetto C, Mazzini L, La Bella V, Mandrioli J, Simone IL, Moglia C, Calvo A, Tarella C, Chio A; STEMALS-II Study Group. Salamone P, et al. BMJ Open. 2020 Mar 24;10(3):e034049. doi: 10.1136/bmjopen-2019-034049. BMJ Open. 2020. PMID: 32209625 Free PMC article.
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression.
Tavazzi E, Daberdaku S, Zandonà A, Vasta R, Nefussy B, Lunetta C, Mora G, Mandrioli J, Grisan E, Tarlarini C, Calvo A, Moglia C, Drory V, Gotkine M, Chiò A, Di Camillo B; Piemonte, Valle d’Aosta Register for ALS (PARALS), for the Emilia Romagna Registry for ALS (ERRALS). Tavazzi E, et al. J Neurol. 2022 Jul;269(7):3858-3878. doi: 10.1007/s00415-022-11022-0. Epub 2022 Mar 10. J Neurol. 2022. PMID: 35266043 Free PMC article.
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.
Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, Restagno G, Brunetti M, Traynor BJ, Nobili F, Carrara G, Fania P, Lopiano L, Valentini MC, Chiò A. Cistaro A, et al. Among authors: brunetti m. Eur J Nucl Med Mol Imaging. 2014 May;41(5):844-52. doi: 10.1007/s00259-013-2667-5. Epub 2014 Jan 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24445987 Free PMC article.
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy.
Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S, Canosa A, Chiò A. Montuschi A, et al. Among authors: brunetti m. J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):168-73. doi: 10.1136/jnnp-2013-307223. Epub 2014 Apr 25. J Neurol Neurosurg Psychiatry. 2015. PMID: 24769471 Free article.
NADPH oxidase (NOX2) activity is a modifier of survival in ALS.
Marrali G, Casale F, Salamone P, Fuda G, Caorsi C, Amoroso A, Brunetti M, Restagno G, Barberis M, Bertuzzo D, Canosa A, Moglia C, Calvo A, Chiò A. Marrali G, et al. Among authors: brunetti m. J Neurol. 2014 Nov;261(11):2178-83. doi: 10.1007/s00415-014-7470-0. Epub 2014 Sep 2. J Neurol. 2014. PMID: 25178511
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor.
Canosa A, Calvo A, Barberis M, Brunetti M, Restagno G, Cammarosano S, Ilardi A, Vigliani MC, Chiò A, Moglia C. Canosa A, et al. Among authors: brunetti m. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):129-30. doi: 10.3109/21678421.2014.969274. Epub 2014 Oct 22. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 25336094 No abstract available.
357 results